Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trials-Reference-Cited by-同舟云学术

Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trials

Author:

Warren Mark¹^ORCID,Chaykin Louis²,Trachtenbarg David³,Nayak Gurudutt⁴,Wijayasinghe Nelun⁴,Cariou Bertrand⁵

Affiliation:

1. Physicians East; Greenville North Carolina

2. Meridien Research; Bradenton Florida

3. University of Illinois College of Medicine at Peoria; Peoria Illinois

4. Novo Nordisk A/S; Søborg Denmark

5. L'Institut du Thorax, Department of Endocrinology; CHU de Nantes; Nantes France

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference17 articles.

2. Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options;Du;Clin Interv Aging,2014

5. Standards of medical care in diabetes-2017;American Diabetes Association;Diabetes Care,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Pharmacotherapy for older people with obesity;European Journal of Internal Medicine;2024-06